Fig. 5From: Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanismEffects of liraglutide on hepatic PCSK9, LDLR and HNF1α expressions in db/db mice and nondiabetic mice. WT wild type, LIRA liraglutideBack to article page